Indiana advocate calls for universal insulin price cap CRAWFORDSVILLE, Ind. (WISH) — For 13 years, Molly King has depended on an insulin drug to manage her Type 1 diabetes. On Dec. 31, that drug will be wiped from the market. King, who lives in Crawfordsville, was 18 when she was first diagnosed with Type 1 diabetes. After much work with a medical team, she was prescribed long-acting insulin drug Levemir. She also takes a short-acting insulin …